Cargando…
Autologous CIK Cell Immunotherapy in Patients with Renal Cell Carcinoma after Radical Nephrectomy
Objective. To evaluate the efficacy of autologous cytokine-induced killer (CIK) cells in patients with renal cell carcinoma (RCC). Methods. 20 patients diagnosed with TNM stage I or II RCC were randomly divided into two groups, a CIK cell treatment group and a control group. The endpoint was progres...
Autores principales: | Zhang, Yajing, Wang, Jin, Wang, Yao, Lu, Xue-Chun, Fan, Hui, Liu, Yang, Zhang, Yan, Feng, Kai-Chao, Zhang, Wen-Ying, Chen, Mei-Xia, Fu, Xiaobing, Han, Wei-Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3872096/ https://www.ncbi.nlm.nih.gov/pubmed/24382970 http://dx.doi.org/10.1155/2013/195691 |
Ejemplares similares
-
The efficacy and safety of the combination of axitinib and pembrolizumab‐activated autologous DC‐CIK cell immunotherapy for patients with advanced renal cell carcinoma: a phase 2 study
por: Song, Meng‐Jia, et al.
Publicado: (2021) -
Cytokine-induced killer (CIK) cell therapy for patients with hepatocellular carcinoma: efficacy and safety
por: Ma, Yue, et al.
Publicado: (2012) -
Autologous CIK cells combined with chemotherapy as the first-line treatment for locally advanced or metastatic gastric cancer is safe and feasible
por: Ma, Xiaoting, et al.
Publicado: (2023) -
Comparison of Laparoscopy and Open Radical Nephrectomy of Renal Cell Cancer
por: Wang, Dong, et al.
Publicado: (2019) -
Adoptive Immunotherapy Strategies with Cytokine-Induced Killer (CIK) Cells in the Treatment of Hematological Malignancies
por: Schmeel, Frederic Carsten, et al.
Publicado: (2014)